Medical tech firm breaks ground on $82 million Huntsville facility
Reading time: 2 minutes
Ground was broken last week for a new Huntsville facility for Glaukos, a global ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases.
This $82 million facility is expected to bring in 154 full-time jobs by 2030.
Medical tech firm Glakous investing in Huntsville
Glaukos Corporation’s research and manufacturing campus will be located in Cummings Research Park on 25 acres adjacent to HudsonAlpha.
The facility will provide research, development and manufacturing capabilities for the company with an option on an additional 15 acres for future expansion.
Mayor Tommy Battle said the company’s decision to expand in Huntsville reflects the city’s collaborative innovation ecosystem, its strong track record in science and technology and its long-term investment in biotech growth.
“For decades, Huntsville has worked to build an environment where science, technology and advanced manufacturing thrive together in a community that knows how to support discovery. Glaukos’ decision to grow here builds on that foundation, showing how our community’s strengths attract companies that are shaping the future of human health around the world.”
Mayor Tommy Battle
Glaukos CEO Thomas Burns said after evaluating over 100 potential sites worldwide, the company chose Huntsville “for its strong talent base and vibrant business climate.”
Want to stay in the know about what’s new and happening in and around Huntsville? Follow us on Facebook, TikTok and Instagram, and be sure to subscribe to our newsletter.
